Amber List

VRDNViridian Therapeutics, Inc.

Healthcare · Biotechnology · mid-cap ($2.2B)
-35.9%
from rolling 252-day high of $34.29 set 2026-01-14 · 211d ago
Current
$21.99
Decline depth
-35.9%
Decline σ
2.6σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$VRDN landed on the list 2026-03-22, down 19.5% from its 52-week high that day — now down -35.9%.

That's 16.1 percentage points deeper than the day it joined. It bottomed 61.2% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-23 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

VRDN qualifies for the Amber List on decline depth.

Decline depth
-35.9%
From rolling 252-day high of $34.29, 211d ago. Past the 30% Amber threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
2.6σ
Drop from local high over the last 5 bars, expressed in units of the stock's typical daily volatility (3.17% per day).

The structural read

What price action says about VRDN.

VRDN qualifies for the Amber List on decline depth — down -35.9% from its rolling 252-day high.

Cross-confirmation: also showing 3/5 bearish time frames.

Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 2D (red), weekly 2U (red), monthly 2U (green).

Earnings on file: 2026-05-05. Tiering is unaffected by earnings dates — listings reflect price structure only.

Questions about VRDN

What people ask.

Why is VRDN on Broken Stocks?

VRDN qualifies for the Amber List on decline depth. It is down -35.9% from its rolling 252-day high of $34.29, set on 2026-01-14 — 211d ago.

Is VRDN a falling knife?

Not by the strict technical definition. VRDN is down -35.9% from its 52-week high, but that high was set 211d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. VRDN is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is VRDN a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is VRDN trading inside its 52-week range?

At $21.99, VRDN sits 41.7% of the way from its 52-week low ($13.18) to its 52-week high ($34.29). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has VRDN been declining?

The current 35.9% decline accrued over 211d, which annualizes to roughly -62.1% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does VRDN compare to its sector?

There are 140 other Healthcare tickers on Broken Stocks: 68 Red, 33 Amber, 39 Watch, with 48 showing recovering structural signals. Median sector decline is -36.0% — VRDN's decline is shallower than the sector median.

Does VRDN's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-05) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.